Klee Justin B. insider trades
Klee Justin B. has filed 24 Form 4s with the SEC that we hold, all for Amylyx Pharmaceuticals, Inc. (AMLX), as Co-Chief Executive Officer, Director. Across all of them we count 0 purchases worth $0 and 20 sales worth $7.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($3.6M). The largest single trade was a sale of 96,555 shares of Amylyx Pharmaceuticals, Inc. worth $3.1M, dated 2023-03-16. Of 2 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-01-10 and the latest 2026-09-14.
Amylyx Pharmaceuticals, Inc. (AMLX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-01-06 | S, sale reported on Form 4 | 1,846 | $67.9K | 2023-01-10 |
| 2023-01-06 | S, sale reported on Form 4 | 4,122 | $148.7K | 2023-01-10 |
| 2023-03-16 | S, sale reported on Form 4 | 96,555 | $3.1M | 2023-03-20 |
| 2023-03-16 | S, sale reported on Form 4 | 3,445 | $111.9K | 2023-03-20 |
| 2024-01-09 | S, sale reported on Form 4 | 5,841 | $95.4K | 2024-01-11 |
| 2024-03-05 | S, sale reported on Form 4 | 4,135 | $77.4K | 2024-03-07 |
| 2024-09-30 | S, sale reported on Form 4 | 18,589 | $59.5K | 2024-10-02 |
| 2025-01-06 | S, sale reported on Form 4 | 7,471 | $30.2K | 2025-01-08 |
| 2025-02-03 | S, sale reported on Form 4 | 11,855 | $41.1K | 2025-02-05 |
| 2025-03-03 | S, sale reported on Form 4 | 4,595 | $14.5K | 2025-03-05 |
| 2025-03-31 | S, sale reported on Form 4 | 21,490 | $74.4K | 2025-04-02 |
| 2025-09-30 | S, sale reported on Form 4 | 29,775 | $427.9K | 2025-10-02 |
| 2025-09-30 | S, sale reported on Form 4 | 200 | $3.0K | 2025-10-02 |
| 2026-01-06 | S, sale reported on Form 4 | 7,715 | $85.6K | 2026-01-08 |
| 2026-01-15 | S, sale reported on Form 4 | 136,193 | $1.8M | 2026-01-20 |
| 2026-01-16 | S, sale reported on Form 4 | 1,995 | $27.7K | 2026-01-20 |
| 2026-02-02 | S, sale reported on Form 4 | 15,500 | $227.7K | 2026-02-04 |
| 2026-03-02 | S, sale reported on Form 4 | 29,282 | $423.7K | 2026-03-04 |
| 2026-09-10 | S, sale reported on Form 4 | 29,025 | $932.6K | 2026-09-14 |
| 2026-09-10 | S, sale reported on Form 4 | 1,439 | $47.7K | 2026-09-14 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1898314) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms